Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-EpCAM (Clone KS1/4)
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-C5aR (Clone 32-G1)
| Applications | IF, WB |
| Reactivities | Human |
Recombinant Anti-CCR9 (Clone 9B1)
| Applications | FC, Neutralize |
| Reactivities | Mouse |
Recombinant Anti-CD106 (Clone B-K9 (C106-K9))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-B7-H6 (Clone 17B1.3)
| Applications | FC, IF |
| Reactivities | Human |
Recombinant Anti-Syntaxin (Clone SP6)
| Applications | IHC, WB |
| Reactivities | Human, Rat, Hamster, Rabbit, Pig, Dog, Guinea Pig, Cow |
Recombinant Anti-Tumor associated glycoprotein (TAG) 72 (Clone B72.3 (Satumomab))
| Applications | FC, IHC |
| Reactivities | Human |
Recombinant Anti-EGFR (Clone C225 (Cetuximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-carcinoembryonic antigen (CEA) (Clone Arcitumomab)
| Applications | FC, IHC |
| Reactivities | Human |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |